Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 1Advanced Breast Cancer 1

Interventions

Tamoxifen 6Specimen Handling 6Anastrozole 3exemestane 2Surveys and Questionnaires 2Radiosurgery 2Letrozole 2Genetic Testing 2Biopsy 2poly ICLC 1elacestrant 1Testosterone 1Standard of Care 1Sentinel Lymph Node Biopsy 1Selective Estrogen Receptor Modulators 1Restraint, Physical 1Radiotherapy 1Practice Guidelines as Topic 1Patient Navigation 1Omacor 1Multicenter Studies as Topic 1Methods 1Meditation 1Medicare 1Mastectomy, Segmental 1Mastectomy 1Granulocyte-Macrophage Colony-Stimulating Factor 1Genetic Counseling 1Follow-Up Studies 1FAPI-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Intraductal, Noninfiltrating × Selective Estrogen Receptor Modulators × Clear all
NCT06218303 2026-03-12

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

University of Pittsburgh

Phase 1 Recruiting
50 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡